These findings are in keeping with recent reports in early‐onset AD, where changes in the innate immune system were already detectable at birth.36 IL‐18 levels were particularly striking in our cohort: they were observed in very high levels in the SC, were the most significantly increased biomarker compared with healthy controls, were strongly associated with barrier function, and also correlated with disease severity. Here, IL18 is linked to Alzheimer disease.